4th annual Biosimilars North America

Conference themes
The first biosimilar product launched in the US in 2015. Currently there are only 4 biosimilar products approved but the North Americas market continues to grow and has become highly lucrative. As such, pharmaceutical companies continue to find ways to differentiate their products in such a saturated market. Thus, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development.

Professional congress organizer (PCO)
SMi Group

https://go.evvnt.com/130541-1

Ms. Honey de Gracia